Alphatec Holdings, Inc.(ATEC) Stock Research - Grey Stern Research

Alphatec Holdings, Inc. (ATEC) Stock Analysis

$9.59 (-4.58%)

ATEC Financial Performance


Use the table below to view Alphatec Holdings, Inc.'s financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q3 - 2024

Metric Value Ranking among Peers
Price $9.59 -
52 Week Low $4.88 -
52 Week High $17.34 -
Market Cap $1.4 Billion 7/17
Gross Margin 100% 1/17
Profit Margin -83% 17/17
EBITDA margin -184% 17/17
Q3 - 2024 Revenue $48.0 Million 11/17
Q3 - 2024 Earnings -$39.6 Million 17/17
Q3 - 2024 Free Cash Flow -$17.1 Million 17/17
Trailing 4 Quarters Revenue $470.0 Million 7/17
Trailing 4 Quarters Earnings -$177.9 Million 17/17
Quarterly Earnings Growth 7% 13/17
Annual Earnings Growth 10% 12/17
Quarterly Revenue Growth -59% 17/17
Annual Revenue Growth 0% 14/17
Cash On Hand $81.0 Million 4/17
Short Term Debt $8.8 Million 6/17
Long Term Debt $555.1 Million 4/17

Alphatec Holdings, Inc. Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare Alphatec Holdings, Inc.'s metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE -1.00 6/17
PS 2.89 10/17
PB 0.00 17/17
PC 16.79 13/17
Liabilities to Equity 0.00 17/17
ROA -0.24 13/17
ROE 130.59 1/17
Current Ratio 1.00 17/17
Quick Ratio 0.11 12/17
Long Term Debt to Equity -407.54 17/17
Debt to Equity -413.99 17/17
Burn Rate 1.26 11/17
Cash to Cap 0.06 5/17
CCR 0.43 9/17
EV to EBITDA -20.83 9/17
EV to Revenue 3.92 6/17

Company Details

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.

CEO: Mr. Patrick Miles

Website: https://www.atecspine.com

Address: 5818 El Camino Real Carlsbad, CALIFORNIA

Exchange: NASDAQ Global Select

Industry: Medical Devices

Alphatec Holdings, Inc. Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to Alphatec Holdings, Inc.. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
LivaNova PLC LIVN $2.7 Billion
AxoGen, Inc. AXGN $645.6 Million
NuVasive, Inc. NUVA $2.1 Billion
Globus Medical, Inc. GMED $11.3 Billion
Integer Holdings Corporation ITGR $4.7 Billion
CONMED Corporation CNMD $2.2 Billion
Orthofix Medical Inc. OFIX $709.3 Million
OrthoPediatrics Corp. KIDS $559.4 Million
Establishment Labs Holdings Inc. ESTA $1.2 Billion
SI-BONE, Inc. SIBN $562.0 Million
Pulmonx Corporation LUNG $243.2 Million
Treace Medical Concepts, Inc. TMCI $482.8 Million
Sight Sciences, Inc. SGHT $187.8 Million
RxSight, Inc. RXST $1.7 Billion
Paragon 28, Inc. FNA $854.8 Million
Artivion, Inc. AORT $1.2 Billion
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
ATEC Income Statements
Quarter Year Revenue Earnings
Q3 2024 $ 48.0 Million -$39.6 Million
Q2 2024 $ 145.6 Million -$40.7 Million
Q1 2024 $ 138.5 Million -$48.5 Million
Q4 2023 $ 138.0 Million -$49.1 Million
Q3 2023 $ 118.3 Million -$42.7 Million
Q2 2023 $ 116.9 Million -$51.4 Million
Q1 2023 $ 109.1 Million -$43.5 Million
Q4 2022 $ 105.9 Million -$35.0 Million

View All

ATEC Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q3 2024 $81.0 Million $745.9 Million $563.9 Million -$1.4 Million
Q2 2024 $99.8 Million $768.6 Million $555.5 Million $40.7 Million
Q1 2024 $144.1 Million $774.6 Million $540.7 Million $61.2 Million
Q4 2023 $221.0 Million $805.2 Million $7.0 Million $101.7 Million
Q3 2023 $122.5 Million $670.2 Million $538.0 Million -$8.9 Million
Q2 2023 $101.0 Million $628.2 Million $487.7 Million -$28.2 Million
Q1 2023 $116.7 Million $569.7 Million $20.9 Million -$58.4 Million
Q4 2022 $84.7 Million $513.4 Million $395.9 Million -$36.7 Million

View All

ATEC Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q3 2024 -$17.1 Million -$11.7 Million -$18.9 Million
Q2 2024 -$47.3 Million -$35.9 Million -$44.3 Million
Q1 2024 -$72.1 Million -$33.6 Million -$76.9 Million
Q4 2023 -$53.2 Million -$28.2 Million $98.4 Million
Q3 2023 $0 $0 $0
Q2 2023 -$38.4 Million -$20.6 Million -$15.7 Million
Q1 2023 -$35.1 Million -$16.8 Million $32.0 Million
Q4 2022 -$23.2 Million -$14.8 Million -$21.4 Million

View All

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions